A phase IV randomised study to assess the tolerability of artesunate-amodiaquine (AS-AQ) (Winthrop® fixed dose combination [FDC]) and artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in Liberia
2017 ◽
Vol 8
(1)
◽
pp. 31-38
◽
2008 ◽
Vol 12
(4)
◽
pp. 430-437
◽
2015 ◽
Vol 26
(12)
◽
pp. 2863-2868
◽
Keyword(s):